Literature DB >> 1737762

Calcium and catecholamine interactions with adrenal chromogranins. Comparison of driving forces in binding and aggregation.

J S Videen1, M S Mezger, Y M Chang, D T O'Connor.   

Abstract

The soluble core of catecholamine storage vesicles in the adrenal medulla contains high concentrations of the cations calcium (20 mM) and catecholamine (600 mM). Do these cations interact with the abundant vesicle core anionic proteins, the chromogranins? We investigated the binding of calcium and norepinephrine (NE) to bovine adrenal chromogranins by equilibrium dialysis. Both calcium and NE were bound saturably by chromogranins, with low affinity (Kd values of 1.3 x 10(-4) M and 2.1 x 10(-3) M), but high capacity (17 and 32 mol of ligand/mol of chromogranin A). Both ligands bound maximally at a pH greater than 5.5 and were displaced by competing cations in a pattern (trivalent greater than divalent greater than monovalent) consistent with electrostatic components to the interactions. Binding of calcium and NE was not impaired by prior heat denaturation of the chromogranins, and chromogranin A was involved in both binding reactions. Calcium but not NE binding was enhanced by nonpolar solvents. Temperature dependence studies indicated that calcium binding to chromogranins was largely entropy-driven, while NE binding was driven by a significantly negative (favorable) change in enthalpy (5760 cal/mol), even in the face of an unfavorable entropy. Exposure of chromogranins to calcium or NE resulted in precipitation (aggregation) as analyzed by centrifugation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. NE was a more effective chromogranin precipitant than calcium, and in combination, the NE effect was antagonized by calcium. Precipitation of chromogranins by both calcium and NE was inhibited by NaCl at ionic strengths comparable with those of the ligands. These data suggest that chromogranins bind and are precipitated by calcium and NE at affinities compatible with their in situ concentrations, but that the interactions exhibit different thermodynamic driving forces. Furthermore, NE may trigger an enthalpy-driven conformational change in chromogranins, resulting in aggregation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737762

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Molecular Mechanism for Hypertensive Renal Disease: Differential Regulation of Chromogranin A Expression at 3'-Untranslated Region Polymorphism C+87T by MicroRNA-107.

Authors:  Kuixing Zhang; Saiful A Mir; C Makena Hightower; Jose Pablo Miramontes-Gonzalez; Adam X Maihofer; Yuqing Chen; Sushil K Mahata; Caroline M Nievergelt; Nicholas J Schork; Barry I Freedman; Sucheta M Vaingankar; Daniel T O'Connor
Journal:  J Am Soc Nephrol       Date:  2014-11-12       Impact factor: 10.121

Review 2.  Chromogranins A and B as regulators of vesicle cargo and exocytosis.

Authors:  José D Machado; Jésica Díaz-Vera; Natalia Domínguez; Carmen M Alvarez; Marta R Pardo; Ricardo Borges
Journal:  Cell Mol Neurobiol       Date:  2010-11-03       Impact factor: 5.046

3.  Exocytotic release from individual granules exhibits similar properties at mast and chromaffin cells.

Authors:  K Pihel; E R Travis; R Borges; R M Wightman
Journal:  Biophys J       Date:  1996-09       Impact factor: 4.033

4.  Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).

Authors:  L Taupenot; S K Mahata; H Wu; D T O'Connor
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

5.  Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin.

Authors:  Nilima Biswas; Sucheta M Vaingankar; Manjula Mahata; Madhusudan Das; Jiaur R Gayen; Laurent Taupenot; Justin W Torpey; Daniel T O'Connor; Sushil K Mahata
Journal:  Endocrinology       Date:  2007-11-08       Impact factor: 4.736

6.  Cellular distribution of chromogranin A in excitatory, inhibitory, aminergic and peptidergic neurons of the rodent central nervous system.

Authors:  M K-H Schafer; S K Mahata; N Stroth; L E Eiden; E Weihe
Journal:  Regul Pept       Date:  2009-12-18

7.  Chromogranin B gene ablation reduces the catecholamine cargo and decelerates exocytosis in chromaffin secretory vesicles.

Authors:  Jésica Díaz-Vera; Yézer G Morales; Juan R Hernández-Fernaud; Marcial Camacho; Mónica S Montesinos; Federico Calegari; Wieland B Huttner; Ricardo Borges; José D Machado
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

Review 8.  Secretory granules in inositol 1,4,5-trisphosphate-dependent Ca2+ signaling in the cytoplasm of neuroendocrine cells.

Authors:  Seung Hyun Yoo
Journal:  FASEB J       Date:  2009-10-16       Impact factor: 5.191

9.  Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo.

Authors:  Teresa Pasqua; Sumana Mahata; Gautam K Bandyopadhyay; Angshuman Biswas; Guy A Perkins; Amiya P Sinha-Hikim; David S Goldstein; Lee E Eiden; Sushil K Mahata
Journal:  Cell Tissue Res       Date:  2015-11-16       Impact factor: 5.249

Review 10.  Chromogranin A: a novel susceptibility gene for essential hypertension.

Authors:  Bhavani S Sahu; Parshuram J Sonawane; Nitish R Mahapatra
Journal:  Cell Mol Life Sci       Date:  2009-11-27       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.